Masked hypertension: a systematic review
The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
The purpose of this research was to review the literature on masked hypertension. Studies, reviews and editorials on masked hypertension were identified by PubMed, Pascal BioMed and Cochrane literature systematic searches. Then, we carried out a meta-analysis of the six cohort studies reporting quantitative data for masked hypertension prognosis. There is still no clear consensus definition of masked hypertension and the reproducibility of the phenomenon is unknown. Nevertheless, the prevalence of masked hypertension seems to lie between 8 and 20%, and can be up to 50% in treated hypertensive patients. Subjects with masked hypertension have a higher risk of cardiovascular accidents [hazard ratios: 1.92 (1.51-2.44)] than normotensive subjects. This is due to a possible failure to recognize and appropriately manage this particular form of hypertension, the frequent association with other risk factors and coexisting target organ damage. The remaining unresolved questions are as follows: is masked hypertension a clinical entity that requires identification and characterization or a statistical phenomenon linked to the variability of blood pressure measurements?; because screening of the entire population is not feasible, how to identify individuals with masked hypertension?; and, in the absence of randomized trial, how to treat masked hypertension?
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“conventional methods of BP assessment conducted in a clinical (office-based) setting at rest fail to identify all cases of high BP, with 8–20% of individuals with normal clinic BP having raised out-of-clinic BP (i.e., masked uncontrolled hypertension).”
From The Identification and Management of High Blood Pressure Using Exercise Blood Pressure: Current Evidence and Practical Guidance (2022) · cites this paper as [4]
In the citing paper
“and may occur in up to 20% of the general population [4], with greater prevalence in those with established disease, such as type 2 diabetes (>30%) [31].”
From The Identification and Management of High Blood Pressure Using Exercise Blood Pressure: Current Evidence and Practical Guidance (2022) · cites this paper as [4]
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
O'Brien, E., Asmar, R., Beilin, L., Imai, Y., Mallion, J.-M., Mancia, G., Mengden, T., Myers, M., Padfield, P., Palatini, P., et al. (2003) · Journal of Hypertension · doi:10.1097/00004872-200305000-00001 · Cited by 1,655
Dolan, E., Stanton, A., Thijs, L., Hinedi, K., Atkins, N., McClory, S., Hond, E. D., McCormack, P., Staessen, J. A., & O’Brien, E. (2005) · Hypertension · doi:10.1161/01.hyp.0000170138.56903.7a · Cited by 1,227
Prognostic Value of Ambulatory Blood-Pressure Recordings in Patients with Treated Hypertension
Clement, D. L., De Buyzere, M. L., De Bacquer, D. A., de Leeuw, P. W., Duprez, D. A., Fagard, R. H., Gheeraert, P. J., Missault, L. H., Braun, J. J., Six, R. O., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022273 · Cited by 1,085
Bobrie, G. (2004) · JAMA · doi:10.1001/jama.291.11.1342 · Cited by 842
Self-citationA general parametric approach to the meta‐analysis of randomized clinical trials
Whitehead, A., & Whitehead, J. (1991) · Statistics in Medicine · doi:10.1002/sim.4780101105 · Cited by 750
Ohkubo, T., Imai, Y., Tsuji, I., Nagai, K., Kato, J., Kikuchi, N., Nishiyama, A., Aihara, A., Sekino, M., Kikuya, M., et al. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816070-00010 · Cited by 741
O'Brien, E., Asmar, R., Beilin, L., Imai, Y., Mancia, G., Mengden, T., Myers, M., Padfield, P., Palatini, P., Parati, G., et al. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000163132.84890.c4 · Cited by 722
Mancia, G., Facchetti, R., Bombelli, M., Grassi, G., & Sega, R. (2006) · Hypertension · doi:10.1161/01.hyp.0000215363.69793.bb · Cited by 691
Research works printed but not linked: 3
- OBrien, 2003, on behalf of the European Society of Hypertension Working Group on blood pressure monitoring., J Hypertens, 21, 821
- Larkin, 1998, Isolated clinic hypertension and normotension: false positives and false negatives in the assessment of hypertension, Blood Press Monit, 3, 247
- OBrien, 2005, on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring., J Hypertens, 23, 697
Cited by
Items 101–200 of 279
Arterial hypertension at the workplace: risk factors and the population value
Strizhakov, L. A., Babanov, S. A., Lebedeva, M. V., Moiseev, S. V., & Fomin, V. V. (2018) · Terapevticheskii arkhiv · doi:10.26442/terarkh2018909138-143 · Cited by 20
The Role of Nocturnal Blood Pressure and Sleep Quality in Hypertension Management
Cappuccio, F. P. (2020) · European Cardiology Review · doi:10.15420/ecr.2020.13 · Cited by 24
Does masked hypertension impact left ventricular deformation?
Tadic, M. V., Cuspidi, C., Vukomanovic, V., Celic, V. P., Tasic, I. S., Stevanovic, A., & Kocijancic, V. (2016) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2016.06.032 · Cited by 20
Cloutier, L., & Lamarre-Cliché, M. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2018.01.012 · Cited by 22
Coccina, F., Pierdomenico, A. M., Cuccurullo, C., Pizzicannella, J., Madonna, R., Trubiani, O., Cipollone, F., & Pierdomenico, S. D. (2020) · American Journal of Hypertension · doi:10.1093/ajh/hpaa078 · Cited by 21
Gorbunov, V. M., Смирнова, М. И., Kurekhyan, A. S., & Drapkina, O. M. (2023) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2023-3666 · Cited by 23
Masked hypertension in obesity: potential predictors and arterial damage
Kenny, I. E., Saeed, S., Gerdts, E., Midtbø, H. B., Halland, H., & Lønnebakken, M. T. (2016) · Blood Pressure Monitoring · doi:10.1097/mbp.0000000000000220 · Cited by 23
Grossman, A., Cohen, N., Shemesh, J., Koren‐Morag, N., Leibowitz, A., & Grossman, E. (2014) · Journal of Clinical Hypertension · doi:10.1111/jch.12303 · Cited by 18
Shin, J., Park, S., Kim, J. H., Ihm, S., Kim, K., Kim, W. S., Pyun, W. B., Kim, Y., Choi, S. I., & Kim, S. K. (2015) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2015.30.5.610 · Cited by 19
“Considering the markedly higher prevalence of MH in the general population, a lower GCR profile or patient selection bias could affect the prevalence of MH [19].”
BackgroundResultUpdate on Hypertension Research in 2021
Mogi, M., Maruhashi, T., Higashi, Y., Masuda, T., Nagata, D., Nagai, M., Bokuda, K., Ichihara, A., Nozato, Y., Toba, A., et al. (2022) · Hypertension Research · doi:10.1038/s41440-022-00967-4 · Cited by 24
Masked Uncontrolled Hypertension Is Not Attributable to Medication Nonadherence
Siddiqui, M., Judd, E. K., Dudenbostel, T., Zhang, B., Gupta, P., Tomaszewski, M., Patel, P., Oparil, S., & Calhoun, D. A. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13258 · Cited by 20
Schrader, B., Schrader, J., Elsässer, A., Bünker, A.-M., Hillmann, B., Vaske, B., Haller, H. G., & Lüders, S. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002588 · Cited by 23
Neurogenic and myogenic resting skin blood flowmotion in subjects with masked hypertension.
Gryglewska, B., Nęcki, M., Cwynar, M., Baron, T., & Grodzicki, T. K. (2010) · PubMed · Cited by 22
Surgical treatment of hepatocellular carcinoma.
Crucitti, F., Furgiuele, S., & Bellantone, R. D. A. (1990) · PubMed · Cited by 18
Sleep-related factors associated with masked hypertension: the Nagahama study
Tabara, Y., Matsumoto, T., Murase, K., Setoh, K., Kawaguchi, T., Nakayama, T., Wakamura, T., Hirai, T., Chin, K., & Matsuda, F. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003466 · Cited by 20
“MHT was defined as awake (mean morning and evening) SBP at least 135mmHg and/or DBP at least 85mmHg [4,18], while sleep hypertension was defined as sleep SBP at least 120mmHg and/or DBP at least 70mmHg.”
MethodOe, Y., Shimbo, D., Ishikawa, J., Okajima, K., Hasegawa, T., Diaz, K. M., Muntner, P., Homma, S., & Schwartz, J. E. (2013) · American Journal of Hypertension · doi:10.1093/ajh/hpt021 · Cited by 18
Wijkman, M. O., Sandberg, K., Kleist, M., Falk, L., & Enthoven, P. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13157 · Cited by 17
Barroso, W. K. S., Jardim, P. C. B. V., Porto, L. B., Araújo, F. A., Sousa, A. L. L., & Salgado, C. M. (2011) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2011005000076 · Cited by 27
Park, S., Park, J. B., Choi, D., Youn, H., Park, C. G., Ahn, Y. K., Shin, J., Kim, D. W., Rim, S., Bae, J. H., et al. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0492 · Cited by 18
Definition of White Coat Hypertension
de la Sierra, A. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01565 · Cited by 15
Ambulatory blood pressure monitoring in childhood and adult obesity
Ben‐Dov, I. Z., & Bursztyn, M. (2009) · Current Hypertension Reports · doi:10.1007/s11906-009-0024-7 · Cited by 17
“Bobrie et al. [ 20 ] concluded that compared with subjects with normal BP or WCH, patients with MH “clearly have a higher BMI, and may even be obese”.”
BackgroundThe NEW-HOPE study and emerging therapies for difficult-to-control and resistant hypertension
Ferdinand, K. C., Harrison, D. E., & Johnson, A. E. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2019.12.008 · Cited by 17
The Complexity of Masked Hypertension: Diagnostic and Management Challenges
Franklin, S. S., & Wong, N. D. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0474-4 · Cited by 14
Should living kidney donors with hypertension be considered for organ donation?
Townsend, R. R., Reese, P. P., & Lim, M. A. (2015) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000169 · Cited by 13
Blood Pressure Treatment Adherence and Control Through 24-Hour Ambulatory Monitoring
Grezzana, G. B., Stein, A. T., & Pellanda, L. C. (2013) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20130046 · Cited by 13
Effects of Nondipping Blood Pressure Changes: A Nephrologist Prospect
Habas, E. M., Akbar, R. A., Alfitori, G. B., Farfar, K. L., Habas, E., Errayes, N., Habas, A., Adab, A. A., Rayani, A., Geryo, N., et al. (2023) · Cureus · doi:10.7759/cureus.42681 · Cited by 23
“The frequency of masked HTN ranges between 8-20% in untreated adults and almost 61% in treated adults [155,156].”
BackgroundAnnual reports on hypertension research 2020
Mogi, M., Higashi, Y., Bokuda, K., Ichihara, A., Nagata, D., Tanaka, A., Node, K., Nozato, Y., Yamamoto, K. I., Sugimoto, K., et al. (2021) · Hypertension Research · doi:10.1038/s41440-021-00766-3 · Cited by 12
Determinants of masked hypertension in the general population: the Finn-Home study
Hänninen, M.-R. A., Niiranen, T., Puukka, P. J., Mattila, A. K., & Jula, A. (2011) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) · Cited by 12
Shang, Z., Wang, W., Li-Yuan, M., Shu-yu, W., & Yi-xin, W. (2009) · Blood Pressure Monitoring · doi:10.1097/mbp.0b013e328332fd25 · Cited by 12
Home and Office Blood Pressure Monitoring in Renal Transplant Recipients
Sberro‐Soussan, R., Rabant, M., Snanoudj, R., Zuber, J., Bererhi, L., Mamzer, M., Legendre, C. M., & Thervet, É. (2012) · Journal of Transplantation · doi:10.1155/2012/702316 · Cited by 12
“This latter may be important since it entailed an increased risk of ESRD, whereas the risk associated with white-coat hypertension was lower [19].”
Latin American recommendations for the management of hypertension in adults (RELAHTA 2)
Sabio, R., Valdez, P. R., Abuabara-Turbay, Y., Belgeri, R. E. A., de Morvil, G. A. A. O., Arias, C., Cámera, L. A., Carballo-Zárate, V., Falcón, H. C., Chahin, R. C., et al. (2019) · Revista Virtual de la Sociedad Paraguaya de Medicina Interna · doi:10.18004/rvspmi/2312-3893/2019.06(01)86-123 · Cited by 22
“Esta prevalencia es altamente variable y se ve incrementada en pacientes jóvenes, sexo masculino, fumadores, diabéticos, presencia de HVI, consumo de alcohol y estrés (44-46) laboral, entre otros factores .”
BackgroundUtilidad de la monitorización ambulatoria de la presión arterial en la toma de decisiones clínicas
Sabater‐Hernández, D., Fikri-Benbrahim, O., & Faus, M. J. (2009) · Medicina Clínica · doi:10.1016/j.medcli.2009.07.019 · Cited by 19
Prognostic Value of Ambulatory Blood Pressure Monitoring
Angeli, F., & Verdecchia, P. (2015) · Springer eBooks · doi:10.1007/978-3-319-22771-9_9 · Cited by 12
Prevalence of Masked Hypertension in African Americans
Larsen, T. R., Gelaye, A., Waanbah, B., Assad, H., Daloul, Y., Williams, F. M. K., Williams, M. J. A., & Steigerwalt, S. P. (2014) · Journal of Clinical Hypertension · doi:10.1111/jch.12418 · Cited by 12
Diagnostic Performance of Blood Pressure Measurement Modalities in Living Kidney Donor Candidates
Armanyous, S. R., Ohashi, Y., Lioudis, M., Schold, J. D., Thomas, G., Poggio, E. D., & Augustine, J. J. (2019) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02780218 · Cited by 11
Masked hypertensives: A disguised arterial stiffness population
Antza, C., Doundoulakis, I., Stabouli, S., Τζιόμαλος, Κ., & Kotsis, V. (2019) · Journal of Clinical Hypertension · doi:10.1111/jch.13692 · Cited by 11
Masked Hypertension: Lessons for the Future.
Penmatsa, K. R., Biyani, M., & Gupta, A. (2020) · PubMed Central · Cited by 11
Groenland, E. H., Vendeville, J.-P. A. C., Bemelmans, R. H. H., Monajemi, H., Bots, M. L., Visseren, F. L. J., & Spiering, W. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19685 · Cited by 14
Hermida, R. C., Ayala, D. E., Ríos, M. T. P., Fernández, J. R., Mojón, A., & Smolensky, M. H. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0445-9 · Cited by 11
Categories of hypertension in the elderly and their 1-year evolution. The Three-City Study
Cacciolati, C., Hanon, O., Dufouil, C., Alpérovitch, A., & Tzourio, C. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835ee0ca · Cited by 14
Diagnostic tests: Home monitoring of blood pressure
McGrath, B. P. (2015) · Australian Prescriber · doi:10.18773/austprescr.2015.005 · Cited by 13
Effort‐reward imbalance and ambulatory blood pressure among female Las Vegas hotel room cleaners
Feaster, M., Arah, O. A., & Krause, N. (2019) · American Journal of Industrial Medicine · doi:10.1002/ajim.22980 · Cited by 13
Kempler, M., Hajdú, N., Putz, Z., Istenes, I., Vági, O. E., Békeffy, M. Z., Schnabel, K. K., Kempler, P., & Körei, A. E. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103322 · Cited by 13
“The prevalence of masked-hypertension ranges up to 20% in population-based studies [19] and it is associated with target-organ damage and poor prognosis [20].”
BackgroundTocci, G., Citoni, B., Nardoianni, G., Figliuzzi, I., & Volpe, M. (2022) · Internal and Emergency Medicine · doi:10.1007/s11739-022-02961-7 · Cited by 13
Optimizing blood pressure control in hypertension: The need to use ABPM
Schmieder, R. E., Lehmann, M., & Schmidt, S. (2012) · Blood Pressure · doi:10.3109/08037051.2012.727253 · Cited by 12
“ABPM, but not clinic BP, can identify patients with masked hypertension, who may have a poor CV prognosis despite apparently well-controlled BP in the clinic (18,19).”
Backgroundde la Sierra, A., Ruilope, L. M., Staplin, N., Stergiou, G. S., & Williams, B. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003950 · Cited by 11
“Masked hypertension is associated with a high cardiovascular risk, with increased rates of cardiovascular events, and mortality [3,4]. was not associated with mortality after adjusting for nocturnal BP [4].”
Blood Pressure Phenotype Variations at Different Gestational Stages and Associated Pregnancy Risks
Zuo, L., Fang, Y., Li, L., Duan, H., Wen, J., Yang, Q., Han, C., Lv, L., & Zhou, X. (2025) · American Journal of Hypertension · doi:10.1093/ajh/hpaf038 · Cited by 11
Biomass Fuel Use and Cardiac Function in Nepali Women
Tiwana, J. K., Benziger, C. P., Hooper, L., Pope, K., Alurkar, V. M., Kafle, R., Sijali, T. R., Balmes, J. R., Kaufman, J. D., & Bates, M. (2020) · Global Heart · doi:10.5334/gh.405 · Cited by 11
“Prior studies evaluating masked hypertension have shown an 8–20% prevalence in the general population and up to 50% prevalence in treated hypertensive patients, although the Nepali population has not been specifically studied [9, 27].”
BackgroundTarget-organ damage and incident hypertension
Kim, S. H., Kim, Y., Kim, J. S., Lim, S. Y., Jung, J. H., Lim, H. E., Kim, E. J., Cho, G., Baik, I., Sung, K., et al. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000000836 · Cited by 10
“First of all, it is important to emphasize that single office BP measurements could not identify masked hypertension or measure the indices of BP variability, which have been known to be associated with TOD [29].”
BackgroundWhat stands behind masked hypertension?
Waeber, B. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e328303180b · Cited by 10
Maruhashi, T., Kinoshita, Y., Ozono, R., Nakamaru, M., Ninomiya, M., Oiwa, J., Kawagoe, T., Yoshida, O., Matsumoto, T., Fukunaga, Y., et al. (2023) · American Journal of Hypertension · doi:10.1093/ajh/hpad014 · Cited by 9
The impact of apelin and relaxin plasma levels in masked hypertension and white coat hypertension
Sanidas, E. A., Tsakalis, K., Papadopoulos, D. P., Zerva, K., Velliou, M., Perrea, D. N., Mantzourani, M., Iliopoulos, D., & Barbetseas, J. D. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13449 · Cited by 8
Stress-induced arterial hypertension
Ambatiello, L. G. (2022) · Terapevticheskii arkhiv · doi:10.26442/00403660.2022.07.201733 · Cited by 14
“Она ассоциирована с молодым возрастом, мужским полом, употреблением алкоголя, курением, высокой физической активностью, дислипидемией, ожирением, нарушением толерантности к углеводам, хронической болезнью почек, семейным анамнезом гипертонии, высоким симпатическим тонусом, сахарным диабетом или риском его развития, а…”
de la Sierra, A. (2015) · Cardiology and Therapy · doi:10.1007/s40119-015-0043-1 · Cited by 9
“Though there is a general consensus that the presence of masked HTN or MUCH confers a risk that may be comparable to that of sustained HTN [18, 19] (possibly from a population perspective the risk is even greater, given that the individuals who do not know they belong to this group are mostly not being treated and out…”
BackgroundAkıllı, H., Kayrak, M., Arıbaş, A., Tekinalp, M., Ayhan, S. S., Gündüz, M., Alibaşiç, H., Altunbaş, G., & Yazıcı, M. (2013) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2013.783047 · Cited by 9
“While the incidence of MHT is between 7% and 17% in the general population (5), the incidence rate for MHT in DM patients has been reported to be as high as 47% (1).”
BackgroundReproducibility of masked uncontrolled hypertension detected through home blood pressure monitoring
Barochiner, J., Posadas‐Martínez, M. L., Martínez, R., & Giunta, D. H. (2019) · Journal of Clinical Hypertension · doi:10.1111/jch.13596 · Cited by 8
Chyu, L., McDade, T. W., & Adam, E. K. (2011) · Biodemography and Social Biology · doi:10.1080/19485565.2011.614572 · Cited by 12
“0% ( Papadopoulos and Makris 2007 ; Bobrie 2008 ).”
BackgroundInfluentialAung, S. M., Güler, A., Güler, Y., Karabay, C. Y., & Akdemir, İ. (2016) · Blood Pressure Monitoring · doi:10.1097/mbp.0000000000000226 · Cited by 8
Lüders, S., Dechend, R., Eckert, S., Mengden, T., Nürnberger, J., Tholl, U., & Sanner, B. M. (2013) · Der Kardiologe · doi:10.1007/s12181-013-0497-0 · Cited by 8
Current approach to masked hypertension: From diagnosis to clinical management
Dolan, E., & James, K. (2013) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12190 · Cited by 9
“44) in people with masked hypertension compared with true normotensive individuals or subjects with controlled hypertension.(68) A further meta-analysis examined seven clinical studies for a total of 11 502 subjects and 912 first CV events.”
BackgroundAmbulatory blood pressure monitoring in the elderly: Features and perspectives
Angeli, F., Verdecchia, P., Poltronieri, C., Bartolini, C., Filippo, V. D., D'Ambrosio, C., & Reboldi, G. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.04.004 · Cited by 9
The association of masked hypertension in treated type 2 diabetic patients with carotid artery IMT
Charvat, J., Chlumský, J., Szabó, M., Žákovičová, E., & Zamrazil, V. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.04.014 · Cited by 8
Wytyczne ESH/ESC dotyczące postępowania w nadciśnieniu tętniczym w 2013 roku
Suplement, K. P. (2013) · Kardiologia Polska · doi:10.5603/kp.2013.0177 · Cited by 18
Wu, Y., Zhang, G., Hu, R., & Du, J. (2020) · Cardiovascular Innovations and Applications · doi:10.15212/cvia.2019.1261 · Cited by 9
Prevalence and factors associated with masked hypertension in chronic kidney disease
Legrand, F., Motiejūnaitė, J., Arnoult, F., Lahens, A., Tabibzadeh, N., Robert, T., Rouzet, F., de Pinho, N. A., Vrtovsnik, F., Flamant, M., et al. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003680 · Cited by 8
Leiria, L. F., Severo, M. D., Ledur, P. D. S., Becker, A. D., Aguiar, F. M., Massierer, D., de Freitas, V. C., Schaan, B. D., & Gus, M. (2014) · Journal of Diabetes · doi:10.1111/1753-0407.12231 · Cited by 11
“Thus, much of the data are derived from subgroup analyses.(8) Given the dearth of literature on this topic, it remains unknown whether hypertensive diabetic patients on antihypertensive drugs are more likely to have WCE or MUH, or whether the latter is underdiagnosed among these patients as compared to hypertensive-on…”
BackgroundManagement of the Hypertensive Child
Ellis, D. (2009) · Springer eBooks · doi:10.1007/978-3-540-76341-3_63 · Cited by 8
A STABILITY OF CARDIOVASCULAR RISK FACTORS BY THE 17-YEAR OBSERVATIONAL STUDY
Владимирович, Д. И., & Karpov, R. S. (2015) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2015-1-67-71 · Cited by 7
“Более высокий регресс АГ среди женщин самой младшей возрастной группы может быть обусловлен высокой вариабельностью АД и тем, что среди женщин этого возраста чаще наблюдается “гипертензия белого халата” [12].”
Filippone, E. J., Foy, A., & Naccarelli, G. V. (2022) · The American Journal of Medicine · doi:10.1016/j.amjmed.2022.05.007 · Cited by 7
Evaluation of Left Ventricular Synchronicity in Hypertensive Patients With Overweight or Obesity
Li, S., Tan, H., Wang, Z., Zhang, Y., Zhong, M., & Zhang, W. (2009) · Obesity · doi:10.1038/oby.2009.476 · Cited by 6
“Furthermore, masked severe high blood pressure in the daily life but not found in the physical examination, or some interleukins such as interleukin-1 and -6 generated from adipocytes may also be reasons resulting in left ventricular electrical and structural remodeling and eventually systolic and diastolic dyssynchro…”
BackgroundIs Mini‐Mental Score Examination Scoring a New Predictor of Uncontrolled Hypertension?
Sayed, K., Taha, T., Saad, M., Mohsen, L., Ibrahiem, M. A., Abdel-Fadeel, N. M., & Sotouhy, A. (2014) · Journal of Clinical Hypertension · doi:10.1111/jch.12319 · Cited by 8
Yano, Y., Poudel, B., Chen, L., Sakhuja, S., Jaeger, B. C., Viera, A. J., Shimbo, D., Clark, D., Anstey, D. E., Lin, F., et al. (2022) · American Journal of Hypertension · doi:10.1093/ajh/hpac027 · Cited by 6
Should we screen for masked hypertension in patient with vascular disease?
Delsart, P., Marboeuf, P., Delhaye, C., Lemesle, G., & Mounier-Vehier, C. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s9980 · Cited by 7
Komori, T., Eguchi, K., Kabutoya, T., Ishikawa, J., Hoshide, S., & Kario, K. (2014) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2014.881839 · Cited by 6
Is Exaggerated Exercise Blood Pressure Increase Related to Masked Hypertension?
Cuspidi, C. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.82 · Cited by 6
Yılmaz, F., Sözel, H., Keleş, M., & Yılmaz, Ü. (2021) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-021-02734-9 · Cited by 7
Ho, J. K., Carnagarin, R., Matthews, V. B., & Schlaich, M. P. (2019) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2018.08.01 · Cited by 6
“Furthermore, masked hypertension, which cannot be detected with office readings, is associated with excess cardiovascular mortality risk (16).”
BackgroundPrevalence and Determinants of Masked Hypertension in Nigeria: The REMAH Study
Odili, A. N., Danladi, B., Chori, B. S., Oshaju, H., Nwakile, P. C., Okoye, I. C., Abdullahi, U. K., Nwegbu, M. M., Zawaya, K., Essien, I., et al. (2020) · American Journal of Hypertension · doi:10.1093/ajh/hpaa211 · Cited by 5
Therapeutic Guidelines: Endocrinology. Version 5.
Tilenus, H. (2015) · Australian Prescriber · doi:10.18773/austprescr.2015.009 · Cited by 5
Increased rate of any retinopathy risk in patients with masked hypertension
Yıldırım, T., Özkan, S., Yılmaz, Ö. Ç., & Yavuz, B. (2019) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2019.1705320 · Cited by 6
“The prevalence of masked hypertension is found in a wide range of 15% to 30% in different population studies (9,10) Achieving a wide range of results in different studies is the result of selection of parameters used in study population selection and masked hypertension definition.”
BackgroundCharacteristics of Patients with Reproducible Masked Hypertension and its Diagnosis Approach
Смирнова, М. И., Gorbunov, V. M., Koshelyaevskaya, Y. N., Деев, А. Д., Volkov, D., Фурман, Н. В., & Dolotovskaya, P. V. (2020) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2019-15-6-789-794 · Cited by 5
Masked hypertension is related to alteration of myocardial arrhythmia Parameters
Yılmaz, Ö. Ç., Özkan, S., & Yavuz, B. (2020) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2020.1812625 · Cited by 5
Comparison of Office, Home, and Ambulatory Blood Pressure in Heart Transplant Recipients
Aquilante, C. L., Page, R. L., II, Vu, A., Roscoe, N., Wolfel, E. E., & Lindenfeld, J. A. (2014) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2014.05.005 · Cited by 5
Determinants of masked hypertension in the general population: the Finn-Home study
Elliott, W. J. (2012) · Yearbook of Cardiology · doi:10.1016/j.ycar.2012.02.003 · Cited by 5
Time to Abandon Clinic Blood Pressure for the Diagnosis of Hypertension?
Williams, B. (2016) · Circulation · doi:10.1161/circulationaha.116.023914 · Cited by 6
Lucinde, R. K., Willkens, M. A., Issarow, B., Fadhil, S. P., Cichowitz, C., Ayieko, P., Kisigo, G., Venkatraman, S., Grosskurth, H., Krieger, A. C., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.043957 · Cited by 7
Hamadou, B., Amougou, S. N., Tchuendem, Y., Nganou–Gnindjio, C. N., Mfeukeu‐Kuate, L., Foka, A. J., Tankeu, A. T., Jingi, A. M., Ménanga, A., & Kingué, S. (2020) · Blood Pressure Monitoring · doi:10.1097/mbp.0000000000000457 · Cited by 4
Vascular α1-Adrenergic Receptor Responsiveness in Masked Hypertension
Yano, Y., Viera, A. J., Hinderliter, A. L., Watkins, L. L., Blumenthal, J. A., Johnson, K. S., Hill, L. K., & Sherwood, A. (2020) · American Journal of Hypertension · doi:10.1093/ajh/hpaa032 · Cited by 5
Epidemiology of Hypertension in Children
Awazu, M. (2015) · Springer eBooks · doi:10.1007/978-3-662-43596-0_54 · Cited by 4
Masked hypertension in untreated normotensives
Enström, I., & Pennert, K. M. (2010) · Blood Pressure Monitoring · doi:10.1097/mbp.0b013e3283419608 · Cited by 4
Duval-Sabatier, A., Brunet, P., Seck, S. M., Haddad, F., Giaime, P., Ramananarivo, P., Bouchouareb, D., & Berland, Y. (2011) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2011.03.012 · Cited by 4
Masked hypertension delaying diagnosis in Gordon's syndrome
Mestre, R. P., Giannini, O., Manzocchi, V., & Bianchetti, M. G. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283580069 · Cited by 4
White Coat and Masked Hypertension
Cuspidi, C., Sala, C., Tadić, M., & Grassi, G. M. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-59918-2_35 · Cited by 4
Masked and White-Coat Hypertension
Verdecchia, P., Angeli, F., & Reboldi, G. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.09.008 · Cited by 5
“Some comprehensive reviews (1–3,10) have shown that the prevalence of MH varies between 8% and 50%, probably depending on differences across studies in several important factors, including baseline office BP, antihypertensive treatment, age, prevalence of smoking, and other demographic features (2,3,10).”
BackgroundPreterm birth and cardiometabolic risk factors in adolescence and early adulthood
Sipola‐Leppänen, M. (2015) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) · Cited by 5
Retinal arteriolar diameters and incident hypertension in initially normotensive individuals
Triantafyllou, Α., Anyfanti, P., & Δούμα, Σ. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000225 · Cited by 4
Hayakawa, M., Hoshide, S., Kanegae, H., & Kario, K. (2025) · Hypertension Research · doi:10.1038/s41440-025-02429-z · Cited by 3
“In addition, home BP has a lower variability and greater reproducibility due to the fact that it is measured routinely under stable and familiar condition [20].”
"Prevalence of Hypertension Among Doctors and Risk Factors in Al-Thawra Hospital, Sanaa in 2019"
Thabit, H. A. (2021) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2021.36.005838 · Cited by 5
Sisó‐Almirall, A., Kostov, B., Blat, E., García, N., de Andres, B., Roura, S., Sierra-Benito, C., Alvira-Balada, M. C., Colungo, C., Benavent-Àreu, J., et al. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000003029 · Cited by 4
“Masked BPH was defined as hypertension with awake-ABPM and normotension with OBPM, HBPM or 1h-AOBP [32].”
MethodHow to Unmask Hidden Cardiovascular Diseases through Preparticipation Screening in Master Athletes?
Zujko, K., & Małek, Ł. A. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2312405 · Cited by 3
“It increases the risk of cardiovascular events and causes destruction of internal organs such as heart failure and renal dysfunction [27,28].”
Background
Metadata
- Authors
- Bobrie, G., Clerson, P., Ménard, J., Postel-Vinay, N., Chatellier, G., & Plouin, P.-F.
- Affiliations
- Assistance Publique – Hôpitaux de Paris (FR)
- Université Paris Descartes (FR)
- Corresponding author
- Bobrie, Guillaume
- Venue
- Journal of Hypertension
- Published
- 2008-09
- Volume
- 26
- Issue
- 9
- Pages
- 1715-1725
- ISSN
- 0263-6352 (ISSN-L)
- OpenAlex
- W1987521955
- Cited by
- 279
- References
- 64
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 4 · 2023: 9 · 2022: 11 · 2021: 10 · 2020: 20 · 2019: 19 · 2018: 14 · 2017: 8 · 2016: 21 · 2015: 24 · 2014: 36 · 2013: 25 · 2012: 15
- FWCI
- 2.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Keywords
- masked hypertension, hypertension, cardiovascular risk, cardiovascular events, prevalence, target organ damage, blood pressure measurement variability, hypertension screening, antihypertensive therapy, prognosis
- MeSH terms
- Humans, Hypertension, Kidney Diseases, Prognosis, Risk Factors, Incidence, Prevalence, Hypertrophy, Left Ventricular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.